The management of premenstrual syndrome: results of a questionnaire survey of women in Lviv pharmacies, Ukraine

Authors

DOI:

https://doi.org/10.15587/2519-4852.2022.260186

Keywords:

premenstrual syndrome, symptoms, management, questionnaire, pharmacotherapy, nonsteroidal anti-inflammatory drugs, herbal remedies, risk factors

Abstract

The aim. To establish the prevalence of PMS symptoms and evaluate the medication management of this disorder in Lviv.

Materials and methods. The objects of the study were: scientific publications related to the problem of PMS; the results (n=105) of the survey. Methods applied: systematization, generalization, comparison, questionnaire. The statistical analyses (descriptive statistics, univariable analysis using simple logistic regression, multiple logistic regression) were performed with SPSS Trial.

Results. The prevalence of PMS among the surveyed was high (83,8 %). The most common complaints are abdominal and/or low back pain (46,6 %) and increased irritability/aggression (43,2 %). Almost half (46,6 %) of women who experienced PMS consult a pharmacist, and only 23,9 % seek medical advice. At the same time, 87,5 % (n=77) of women (among those suffering from PMS) use medicines to alleviate/eliminate the symptoms of PMS. Nonsteroidal anti-inflammatory drugs (77,6 %), sedatives (36,8 %), and complex herbal remedies that affect the genital system (18,4 %) are the most common drugs for PMS.

Choosing the way of PMS management, 44,8 % of women would prefer herbal medicines to synthetic ones. Both previous using of synthetic drugs for PMS and adverse drug reactions to synthetic drugs have a statistically significant contribution to a positive attitude towards herbal remedies (p=0,004 and p=0,026, respectively).

Conclusion. PMS is a common medical and social issue. Achieving effective and safe medication management of PMS requires the joint participation of a physician, pharmacist, and the patient in terms of compliance and lifestyle adjustments

Author Biographies

Khrystyna Makukh, Danylo Halytsky Lviv National Medical University

PhD, Associate Professor

Department of HealthCare Management, Pharmacotherapy and Clinical Pharmacy

Oksana Horodnycha, Danylo Halytsky Lviv National Medical University

PhD, Assistant

Department of HealthCare Management, Pharmacotherapy and Clinical Pharmacy

Oksana Nepyivoda, Danylo Halytsky Lviv National Medical University

Assistant

Department of HealthCare Management, Pharmacotherapy and Clinical Pharmacy

References

  1. Yesildere Saglam, H., Orsal, O. (2020). Effect of exercise on premenstrual symptoms: A systematic review. Complementary Therapies in Medicine, 48, 102272. doi: http://doi.org/10.1016/j.ctim.2019.102272
  2. Hofmeister, S., Bodden, S. (2016). Premenstrual syndrome and premenstrual dysphoric disorder. American family physician, 94 (3), 236–240. Available at: https://www.aafp.org/afp/2016/0801/p236.html
  3. Buddhabunyakan, N., Kaewrudee, S., Chongsomchai, C., Soontrapa, S., Somboonporn, W., Sothornwit, J. (2017). Premenstrual syndrome (PMS) among high school students. International Journal of Women’s Health, 9, 501–505. doi: http://doi.org/10.2147/ijwh.s140679
  4. Direkvand-Moghadam, A., Sayehmiri, K., Delpisheh, A., Sattar, K (2014). Epidemiology of premenstrual syndrome (pms) – a systematic review and meta-analysis study. J Clin. Diagn Res, 8 (2), 106–109. doi: http://doi.org/10.7860/jcdr/2014/8024.4021
  5. Shahbazi, F., Eslampanah, Z., Niaparast, M. (2020). Prevalence of symptoms and medication use among female medical students and pharmacy clients with premenstrual syndrome: a cross‐sectional study in Iran. Journal of Pharmacy Practice and Research, 50 (1), 55–60. doi: http://doi.org/10.1002/jppr.1609
  6. Mohib, A., Zafar, A., Najam, A., Tanveer, H., Rehman, R. (2018). Premenstrual Syndrome: Existence, Knowledge, and Attitude Among Female University Students in Karachi. Cureus, 10 (3), e2290. doi: http://doi.org/10.7759/cureus.2290
  7. Dennerstein, L., Lehert, P., Keung, L. S., Pal, S. A., Choi, D. (2010). Asian study of effects of premenstrual symptoms on activities of daily life. Menopause International, 16 (4), 146–151. doi: http://doi.org/10.1258/mi.2010.010035
  8. Hamaideh, S. H., Al-Ashram, S. A., Al-Modallal, H. (2013). Premenstrual syndrome and premenstrual dysphoric disorder among Jordanian women. Journal of Psychiatric and Mental Health Nursing, 21 (1), 60–68. doi: http://doi.org/10.1111/jpm.12047
  9. Maged, A. M., Abbassy, A. H., Sakr, H. R. S., Elsawah, H., Wagih, H., Ogila, A. I., Kotb, A. (2018). Effect of swimming exercise on premenstrual syndrome. Archives of Gynecology and Obstetrics, 297 (4), 951–959. doi: http://doi.org/10.1007/s00404-018-4664-1
  10. Mohebbi Dehnavi, Z., Jafarnejad, F., Sadeghi Goghary, S. (2018). The effect of 8 weeks aerobic exercise on severity of physical symptoms of premenstrual syndrome: a clinical trial study. BMC Women’s Health, 18 (1). doi: http://doi.org/10.1186/s12905-018-0565-5
  11. Pakharenko, L. V. (2014). Hormonal aspects of premenstrual syndrome. Women's health, 10 (96), 144–146.
  12. Tatarchuk, T. F., Zakharenko, N. F., Manoliak, I. P. (2018). Premenstrual syndrome. Pathogenetic aspects of treatment. Reproductive Endocrinology, 5 (43), 50–54. doi: http://doi.org/10.18370/2309-4117.2018.43.50-54
  13. Franchuk, O. S., Franchuk, M. O. (2019). Treatment of premenstrual syndrome with the use of adaptol and sedative preparations of plant origin. Actual Problems of Pediatrics, Obstetrics and Gynecology, 1, 136–139. doi: http://doi.org/10.11603/24116-4944.2019.1.10202
  14. Bulavenko, O. V., Palapa, V. V., Dzis, N. P. (2014). Investigation of life quality in women of early reproductive age with edematous form of premenstrual sindrome. Reports of Vinnytsia National Medical University, 18 (2), 508–512. Available at: https://dspace.vnmu.edu.ua/handle/123456789/5133
  15. Potter, J., Bouyer, J., Trussell, J., Moreau, C. (2009). Premenstrual Syndrome Prevalence and Fluctuation over Time: Results from a French Population-Based Survey. Journal of Women’s Health, 18 (1), 31–39. doi: http://doi.org/10.1089/jwh.2008.0932
  16. Czajkowska, M., Drosdzol-Cop, A., Gałązka, I., Naworska, B., Skrzypulec-Plinta, V. (2015). Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorder in Adolescent Athletes. Journal of Pediatric and Adolescent Gynecology, 28 (6), 492–498. doi: http://doi.org/10.1016/j.jpag.2015.02.113
  17. Bianco, V., Cestari, A. M., Casati, D., Cipriani, S., Radici, G., Valente, I. (2014). Premenstrual syndrome and beyond: lifestyle, nutrition, and personal facts. Minerva ginecologica, 66 (4), 365–375. Available at: https://pubmed.ncbi.nlm.nih.gov/25020055/
  18. Geta, T. G., Woldeamanuel, G. G., Dassa, T. T. (2020). Prevalence and associated factors of premenstrual syndrome among women of the reproductive age group in Ethiopia: Systematic review and meta-analysis. PLOS ONE, 15 (11), e0241702. doi: http://doi.org/10.1371/journal.pone.0241702
  19. Ezeh, O., Ezeh, C. (2016). Prevalence of prementrual syndrome and copıng strategıes among school gırls. African Journal for The Psychological Studies of Social Issues, 19 (2), 111–119. Available at: https://www.ajol.info/index.php/ajpssi/article/view/176111
  20. Shrestha, D. B., Shrestha, S., Dangol, D., Aryal, B. B., Shrestha, S., Sapkota, B., Rai, S. (2019). Premenstrual Syndrome in Students of a Teaching Hospital. Journal of Nepal Health Research Council, 17 (2), 253–257. doi: http://doi.org/10.33314/jnhrc.v0i0.1213
  21. Lete, I., Dueñas, J. L., Serrano, I., Doval, J. L., Martínez-Salmeán, J., Coll, C. et. al. (2011). Attitudes of Spanish women toward premenstrual symptoms, premenstrual syndrome and premenstrual dysphoric disorder: results of a nationwide survey. European Journal of Obstetrics & Gynecology and Reproductive Biology, 159 (1), 115–118. doi: http://doi.org/10.1016/j.ejogrb.2011.06.041
  22. Śliwerski, A., Koszałkowska, K. (2021). The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory. Life, 11 (11), 1278. doi: http://doi.org/10.3390/life11111278
  23. Abeje, A., Berhanu, Z. (2019). Premenstrual syndrome and factors associated with it among secondary and preparatory school students in Debremarkos town, North-west Ethiopia, 2016. BMC Research Notes, 12 (1). doi: http://doi.org/10.1186/s13104-019-4549-9
  24. Yoshimi, K., Shiina, M., Takeda, T. (2019). Lifestyle Factors Associated with Premenstrual Syndrome: A Cross-sectional Study of Japanese High School Students. Journal of Pediatric and Adolescent Gynecology, 32 (6), 590–595. doi: http://doi.org/10.1016/j.jpag.2019.09.001
  25. Seedhom, A. E., Mohammed, E. S., Mahfouz, E. M. (2013). Life Style Factors Associated with Premenstrual Syndrome among El-Minia University Students, Egypt. ISRN Public Health, 2013, 1–6. doi: http://doi.org/10.1155/2013/617123
  26. Rezende, A. P. R., Alvarenga, F. R., Ramos, M., Franken, D. L., Dias da Costa, J. S., Pattussi, M. P., Paniz, V. M. V. (2022). Prevalence of Premenstrual Syndrome and Associated Factors Among Academics of a University in Midwest Brazil. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, 44 (2), 133–141. doi: http://doi.org/10.1055/s-0041-1741456
  27. The State Register of Drugs of Ukraine. Available at: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument
  28. Albsoul-Younes, A., Alefishat, E., Farha, R. A., Tashman, L., Hijjih, E., AlKhatib, R. (2017). Premenstrual syndrome and premenstrual dysphoric disorders among Jordanian women. Perspectives in Psychiatric Care, 54 (3), 348–353. doi: http://doi.org/10.1111/ppc.12252
  29. Marjoribanks, J., Ayeleke, R. O., Farquhar, C., Proctor, M. (2015). Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews. doi: http://doi.org/10.1002/14651858.cd001751.pub3
  30. Cerqueira, R. O., Frey, B. N., Leclerc, E., Brietzke, E. (2017). Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Archives of Women’s Mental Health, 20 (6), 713–719. doi: http://doi.org/10.1007/s00737-017-0791-0
  31. Ooi, S. L., Watts, S., McClean, R., Pak, S. C. (2020). Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-Analysis. Journal of Women’s Health, 29 (2), 262–278. doi: http://doi.org/10.1089/jwh.2019.7770
  32. Canning, S., Waterman, M., Orsi, N., Ayres, J., Simpson, N., Dye, L. (2010). The Efficacy of Hypericum perforatum (St Johnʼs Wort) for the Treatment of Premenstrual Syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs, 24 (3), 207–225. doi: http://doi.org/10.2165/11530120-000000000-00000
  33. Ghazanfarpour, M., Kaviani, M., Asadi, N., Ghaffarpasand, F., Ziyadlou, S., Tabatabaee, H. R., Dehghankhalili, M. (2011). Hypericum perforatumfor the treatment of premenstrual syndrome. International Journal of Gynecology & Obstetrics, 113 (1), 84–85. doi: http://doi.org/10.1016/j.ijgo.2010.11.007
  34. Jang, S. H., Kim, D. I., Choi, M.-S. (2014). Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complementary and Alternative Medicine, 14 (1). doi: http://doi.org/10.1186/1472-6882-14-11
  35. Shahmohammadi, A., Ramezanpour, N., Mahdavi Siuki, M., Dizavandi, F., Ghazanfarpour, M., Rahmani, Y. et. al. (2019). The efficacy of herbal medicines on anxiety and depression in peri- and postmenopausal women: A systematic review and meta-analysis. Post Reproductive Health, 25 (3), 131–141. doi: http://doi.org/10.1177/2053369119841166
  36. Leach, M. J., Moore, V. (2012). Black cohosh (Cimicifuga spp.) for menopausal symptoms. The Cochrane database of systematic reviews. doi: http://doi.org/10.1002/14651858.cd007244.pub2

Downloads

Published

2022-06-30

How to Cite

Makukh, K., Horodnycha, O., & Nepyivoda, O. (2022). The management of premenstrual syndrome: results of a questionnaire survey of women in Lviv pharmacies, Ukraine. ScienceRise: Pharmaceutical Science, (3(37), 27–33. https://doi.org/10.15587/2519-4852.2022.260186

Issue

No. 3(37) (2022)

Section

Pharmaceutical Science

License

Copyright (c) 2022 Khrystyna Makukh, Oksana Horodnycha, Oksana Nepyivoda

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.